Unknown

Dataset Information

0

Analysis of SDHD promoter mutations in various types of melanoma.


ABSTRACT: Recently, recurrent mutations in regulatory DNA regions, such as promoter mutations in the TERT gene were identified in melanoma. Subsequently, Weinhold et al. reported SDHD promoter mutations occurring in 10% of melanomas and being associated with a lower overall survival rate. Our study analyzes the mutation rate and clinico-pathologic associations of SDHD promoter mutations in a large cohort of different melanoma subtypes.451 melanoma samples (incl. 223 non-acral cutaneous, 38 acral, 33 mucosal, 43 occult, 43 conjunctival and 51 uveal melanoma) were analyzed for the presence of SDHD promoter mutations by Sanger-sequencing. Statistical analysis was performed to screen for potential correlations of SDHD promoter mutation status with various clinico-pathologic criteria.The SDHD promoter was successfully sequenced in 451 tumor samples. ETS binding site changing SDHD promoter mutations were identified in 16 (4%) samples, of which 5 mutations had not been described previously. Additionally, 5 point mutations not located in ETS binding elements were identified. Mutations in UV-exposed tumors were frequently C>T. One germline C>A SDHD promoter mutation was identified. No statistically significant associations between SDHD promoter mutation status and various clinico-pathologic variables or overall patient survival were observed.Melanomas harbor recurrent SDHD promoter mutations, which occur primarily as C>T alterations in UV-exposed melanomas. In contrast to the initial report and promoter mutations in the TERT gene, our analysis suggests that SDHD promoter mutations are a relatively rare event in melanoma (4% of tumors) of unclear clinical and prognostic relevance.

SUBMITTER: Scholz SL 

PROVIDER: S-EPMC4694872 | biostudies-other | 2015 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications


<h4>Objectives</h4>Recently, recurrent mutations in regulatory DNA regions, such as promoter mutations in the TERT gene were identified in melanoma. Subsequently, Weinhold et al. reported SDHD promoter mutations occurring in 10% of melanomas and being associated with a lower overall survival rate. Our study analyzes the mutation rate and clinico-pathologic associations of SDHD promoter mutations in a large cohort of different melanoma subtypes.<h4>Methods</h4>451 melanoma samples (incl. 223 non-  ...[more]

Similar Datasets

2015-02-28 | GSE63543 | GEO
| S-EPMC6424452 | biostudies-literature
| S-EPMC8238633 | biostudies-literature
2015-02-28 | E-GEOD-63543 | biostudies-arrayexpress
| S-EPMC4423787 | biostudies-literature
| S-EPMC4698275 | biostudies-literature
| S-EPMC6711603 | biostudies-literature
| S-EPMC6411457 | biostudies-literature
| S-EPMC5250687 | biostudies-literature
| S-EPMC6726741 | biostudies-literature